Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

CSL Ltd

CSJ
Current price
178.72 EUR +0.24 EUR (+0.13%)
Last closed 300.26 AUD
ISIN AU000000CSL8
Sector Healthcare
Industry Biotechnology
Exchange Frankfurt Exchange
Capitalization 143 726 318 973 AUD
Yield for 12 month +11.68 %
1Y
3Y
5Y
10Y
15Y
CSJ
21.11.2021 - 28.11.2021

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia. Address: 655 Elizabeth Street, Melbourne, VIC, Australia, 3000

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

484.88 AUD

P/E ratio

36.3831

Dividend Yield

1.32 %

Current Year

+33 210 661 299 AUD

Last Year

+29 014 679 452 AUD

Current Quarter

+15 024 942 057 AUD

Last Quarter

+18 198 292 121 AUD

Current Year

+16 166 741 931 AUD

Last Year

+14 022 807 353 AUD

Current Quarter

+6 842 820 053 AUD

Last Quarter

+9 334 145 841 AUD

Key Figures CSJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 4 611 447 456 AUD
Operating Margin TTM 19.02 %
PE Ratio 36.3831
Return On Assets TTM 6.56 %
PEG Ratio
Return On Equity TTM 14.58 %
Wall Street Target Price 484.88 AUD
Revenue TTM 14 779 000 484 AUD
Book Value 35.88 AUD
Revenue Per Share TTM
Dividend Share 2.64 AUD
Quarterly Revenue Growth YOY 10.1 %
Dividend Yield 1.32 %
Gross Profit TTM 6 834 289 143 AUD
Earnings per share 8.16 AUD
Diluted Eps TTM 8.16 AUD
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY 30.7 %
Profit Margin 17.85 %

Dividend Analytics CSJ

Dividend growth over 5 years

59 %

Continuous growth

3 years

Payout Ratio 5 years average

67 %

Dividend History CSJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 3.97
Ex Dividend Date 09.09.2024
Forward Annual Dividend Yield 1.32 %
Last Split Factor 3:1
Payout Ratio 45.18 %
Last Split Date 18.10.2007
Dividend Date

Stock Valuation CSJ

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 36.3831
Forward PE 35.461
Enterprise Value Revenue 7.3209
Price Sales TTM 9.7249
Enterprise Value EBITDA 22.722
Price Book MRQ 5.5876

Financials CSJ

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CSJ

For 52 weeks

225.24 AUD 310.84 AUD
50 Day MA 305.19 AUD
Shares Short Prior Month
200 Day MA 289.52 AUD
Short Ratio
Shares Short
Short Percent